Table 1.
Characteristics of the large-scale adenoma data sets included in this study.
| Study | Group (Na) | Age (average ± s.db) | BMI (average ± s.db) | Sex F(%)/M(%)c | No. of reads (average ± s.db) | Country |
|---|---|---|---|---|---|---|
| CA12 | Control (30) | 55.27 ± 9.22 | 26.73 ± 5.19 | 63.30/36.70 | 109,885 ± 55,194 | USA Canada |
| Adenoma (30) | 61.30 ± 11.15 | 27.40 ± 4.45 | 60.00/40.00 | |||
| Cancer (30) | 59.40 ± 10.99 | 30.59 ± 7.18 | 70.00/30.00 | |||
| FR21 | Control (50) | 62.32 ± 8.98 | 24.66 ± 4.69 | 52.00/48.00 | 215,465 ± 119,217 | France |
| Adenoma (38) | 62.29 ± 8.51 | 27.40 ± 4.45 | 28.90/71.10 | |||
| Cancer (41) | 65.51 ± 10.51 | 30.59 ± 7.18 | 41.50/58.50 | |||
| US140 | Adenoma (40) | 62.33 ± 9.12 | 26.22 ± 4.22 | 37.50/62.50 | 48,337 ± 25,069 | USA |
| Cancer (26) | 61.65 ± 12.89 | 28.63 ± 7.19 | 42.30/57.70 | |||
| US227 | Control (172) | 54.29 ± 9.93 | 26.69 ± 5.33 | 64.50/35.50 | 52,028 ± 36,596 | USA |
| Adenoma (198) | 63.35 ± 11.47 | 26.27 ± 4.73 | 40.40/59.60 | |||
| Cancer (120) | 63.78 ± 12.89 | 28.89 ± 7.25 | 43.30/56.70 | |||
| Control (252) | 56.00 ± 10.14 | 26.48 ± 5.25 | 61.90/38.10 | |||
| Total | Adenoma (306) | 62.89 ± 10.80 | 26.21 ± 4.80 | 38.89/61.11 | 85,637 ± 85,460 | |
| Cancer (217) | 63.25 ± 12.28 | 28.30 ± 7.23 | 41.01/58.99 |
All data sets were sequencing data of the V4 region of the 16S rRNA gene.
aNumber of samples.
bStandard deviation.
cThe ratio of the percentage of female and male.